Bedside Cell Therapies: Point-of-Care Manufacturing Is Slowly Becoming a Reality
June 16, 2023
Tags:
Decentralized manufacturing models in which cell therapies are produced in automated, closed manufacturing systems at the point of care are actively being pursued as a means to shorten therapy manufacturing times and lower treatments costs.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
